LBC

Biodyne Invests ₩8 Billion in Vietnam Production Facility for Earlypap Launch

by

Biodyne Sets Sights on Global Market with Earlypap Mass Production Liquid-based cytology (LBC) specialist Biodyne is gearing up for global market entry with its self-sampling brush, Earlypap. The company’s ₩8 billion investment in a Vietnam production facility represents a significant step. This article delves into the investment rationale, potential benefits and risks, and key insights … Read more

Biodyne’s After-Hours Trading Surge: What Does ₩16.8B Mean for Investors?

by

Biodyne Sees ₩16.8 Billion After-Hours Trading Surge: What Happened? On August 6, 2025, Biodyne experienced a significant after-hours trading volume totaling ₩16.8 billion. With institutional investors net buying ₩3 billion, what impact will this transaction have on Biodyne’s stock price? This article analyzes the background and implications of this large trade, and highlights key points … Read more